Natriuretic peptides, particularly NT-proBNP, enable the detection of subclinical cardiac dysfunction [26] and provide valuable prognostic information on mortality risk in patients with diabetes, kidney disease, or CVD, while further research is needed to investigate its role in optimizing cardiorenal therapies [25]. This evidence concerns the gene NPPB and diabetes mellitus.